Pharmaceutically acceptable salt of a substituted 3-indazolyl-4-pyridylisothiazole compound

Abstract

The present invention provides a pharmaceutically acccptable salt of a compound of formula I wherein R1 is H or C1-C3 alkyl; R2 is H, C1-C3 alkyl, C3-C5 cycloalkyl, C1 C3 fluoroalkyl, NR4R5, C1-C3 alkoxy or C1-C3 alkoxymethyl; R3 is H or methyl; and R4 and R5 are independently H or C1-C3 alkyl, and pharmaceutical composition thereof.